庞大的市场需求推动助听器市场的繁荣。根据贝哲斯咨询的调研数据，2024年全球助听器市场规模达801亿美元，预计在2024-2029年预测期内将以5.8%的 复合年增长率增长。 然而，传统助听器市场存在诸多痛点： 自从2018年西万拓和唯听合并为WS Audiology后，传统听力设备巨头之间的大规模整合浪潮曾一度放缓。而近日，美国听力行业迎来突破性事件—— Eargo与hearX合并，诞生了一家新的OTC助听器公司LXE Hearing。 作为2022年FDA批准OTC（非处方）助听器销售以来的首起重大战略合并，此次交易获Patient Square Capital注资1亿美元（约合人民币7.2亿元）。此前， 这家专注于优质医疗健康企业的投资机构，已于2024年完成对Eargo的私有化运作，此番再度入局凸显了市场对直接面向消费者的听力解决方案的强烈信 心。 LXE Hearing将整合双方在产品设计、数字技术及用户布局的核心优势，凭借25年行业经验实现资源互补。新公司的战略目标明确：为听损人群提供触手 可及且经济实惠的听力健康服务，增强服务可及性与用户体验。 FDA批准非处方助听器销售， Eargo与hear ...

Core Insights - The article highlights the launch of the RIC3.0 Pro hearing aid by the domestic brand Zhiting, emphasizing its technological advancements and commitment to social responsibility [1][7]. Group 1: Technological Advancements - The RIC3.0 Pro features a self-developed 6nm chip from Tsinghua University, which enhances processing power by three times compared to imported products, enabling noise suppression and voice enhancement within 7 milliseconds [3]. - The product incorporates AI noise reduction algorithms optimized in collaboration with Tencent, improving voice clarity by 40% in typical high-frequency environments for elderly users [3]. - The RIC3.0 Pro has received the German Red Dot Award in 2024, showcasing its recognized quality and innovative features such as voice assistant integration and enhanced durability [3]. Group 2: Comprehensive Ecosystem - Zhiting has established a fully autonomous industry chain covering research, production, and service, setting a benchmark in the industry [5]. - The company collaborates with leading academic institutions to create a technology closed loop for chip design, algorithm development, and manufacturing [5]. - Zhiting's production facility has a capacity exceeding 100,000 units annually, with a quality rate of 99.8%, certified by both Chinese and U.S. regulatory bodies [5]. Group 3: Social Responsibility and Brand Credibility - Zhiting engages in social initiatives, donating devices to over 20,000 hearing-impaired veterans across 10 provinces and implementing a "buy one, donate one" model [7]. - The brand has been recognized as one of the top ten hearing aid brands on platforms like JD Health and Tmall Health for three consecutive years, reflecting its commitment to customer service [7]. - The company has formed partnerships with Tencent and other tech giants to enhance health management services, addressing challenges in remote areas [11]. Group 4: Industry Leadership - Zhiting aims to transition the Chinese hearing aid industry from a follower to a leader through technological innovation and social initiatives [11]. - The company has initiated a recruitment drive for partners to promote sustainable development in hearing health technology [11].

积极应对人口老龄化国家战略促使国内医疗级助听器行业稳健增长。 本文为IPO早知道原创 作者｜C叔 微信公众号｜ipozaozhidao 据 IPO 早知道消息， 5 月 22 日，博音听力 技术（上海）有限公司（下称 "博音听力"） 宣布 B 轮获数千万元增资， 本轮 投资方苏州国发创业投资控股有限公司 ， 为 苏创投集团旗下专业股权投 资机构。 本次融资 将 帮助公司 持续加大国产助听器研发投入及专业服务机构布局。 博音听力 成立于 2019 年，是一家以投资健康产业为主，专注发展" AI 智能助听器 + 听力专家中 心"的集设计研发、生产、销售于一体的国家高新技术企业。 成立后，公司曽获得铱创投资、苏高新 创投集团、君联资本、明熙资本等机构的投资。 2025 年 1 月 ， 公司宣布完成 广州产投、曜金资 本联合领投 的近亿元 B 轮融资 。 博音听力创始人江显全 在 听力行业 有超 25 年 经验 ，曾在国际龙头助听器公司负责中国区的零 售、销售、市场等 18 年，深知国内助听器产品、渠道、消费者需求等重要路径以及发展趋势。博音 听力核心团队曾供职于全球知名助听器集团的核心岗位。 博音听力已推出 "唐潮 ...

报名：首届全球眼科大会 | 议程更新 报名：首届全球骨科大会 | 议程更新 报名：首届全球心血管大会 | 奖项申报 合作伙伴征集：2025全球手术机器人大会 近日， Eargo 和 Hearx 合并成立了名为 LXE Hearing 的助听器公司， 由于 Lexie 和 Eargo 都是私营公司，因此关于其设备商业表现的公开信息较少。 合并公告引用了行业数据公司 Circana 的一份报告，该报告显示，从 2023 年 8 月到 2024 年 7 月，Lexie 是美国排名第一的助听器品牌。 Patient Square Capital 于 2024 年将 Eargo 私有化，该公司已向合并后的公司投资了 1 亿美元（超7亿人民币） 。LXE 表示，这笔投资反映了对直接面 向患者的助听器市场的信心。 # 合 并 详情 非处方购买助听器的选项吸引了众多新进入者：索尼、惠普已经进入市场，Lexie 与 Bose 合作，而 Eargo 本身此前已在直接向消费者销售产品，因此面临 了更激烈的竞争。苹果公司也在去年进入该市场。 在应对美国司法部调查的后果中，Eargo 的毛系统出货量从 2021 年的 45,136 台 ...

Core Viewpoint - The article discusses the potential of AI and deep learning technologies to revolutionize the hearing aid industry, addressing long-standing challenges in sound recognition and user satisfaction [5][6][9]. Group 1: Current Market Landscape - The hearing aid market is dominated by five major companies: Sonova, Demant, Starkey, which control over 90% of sales [5]. - Despite advancements, many new tech companies face challenges in core algorithms and chip monopolies [5][6]. - The penetration rate of hearing aids remains low, with only 6.5% of users satisfied with their devices [6][7]. Group 2: Technological Advancements - AI and deep learning models like DeepSeek are providing new opportunities for hearing aid manufacturers to enhance product capabilities [5][9]. - Traditional hearing aids rely on digital signal processing algorithms that struggle with noise cancellation and voice recognition in complex environments [8][9]. - Recent innovations include deep neural networks (DNN) that allow hearing aids to learn from real-world sounds, improving their performance in noisy settings [8][9][10]. Group 3: Consumer Trends and Market Dynamics - There is a growing consumer awareness and acceptance of professional hearing aids, moving away from low-cost sound amplifiers [12]. - The distinction between medical-grade and consumer-grade hearing aids is significant, with prices ranging from 5,000 to 40,000 yuan for medical-grade devices, while consumer-grade devices are priced between 1,500 and 4,000 yuan [13]. - The emergence of consumer-grade hearing aids aims to reduce costs and improve accessibility, potentially allowing new entrants to capture market share [12][13]. Group 4: Future Outlook - The article suggests that consumer-grade hearing aids will become an important segment of the market, although they may not fully replace professional fitting services [15]. - The competitive landscape may remain dominated by established players in the short term, but long-term success will depend on factors like pricing, understanding of local language contexts, and after-sales service [15][16].